Evidence map›Paper›PMID 29790485›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2018

Bibliometric Analysis of Tumor Immunotherapy Studies.

Kaining Lu, Shan Yu, Meng Yu, Dan Sun, Zhihong Huang, Haotian Xing, Jianbin Bi, Zeliang Li, Zhenhua Li, Xiankui Liu and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Bibliometric Study of Exercise and Tendinopathy Research from 2001 to 2020.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Bibliometric Analysis of Pediatric Liver Transplantation Research in PubMed from 2014 to 2018.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Top-100 Most Cited Publications Concerning Network Pharmacology: A Bibliometric Analysis.Evidence-based complementary and alternative medicine : eCAM · 2019
    Review
  19. Scientometric Analysis of SIRT6 Studies.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kaining LuDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Shan YuDepartment of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, Key Laboratory of Medical Cell Biology, Ministry of Education, College of Basic Medical Science, China Medical University, Shenyang, Liaoning, China (mainland).
Meng YuDepartment of Reproductive Biology and Transgenic Animals, China Medical University, Shenyang, Liaoning, China (mainland).
Dan SunDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Zhihong HuangDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Haotian XingDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Jianbin BiDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Zeliang LiDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Zhenhua LiDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Xiankui LiuDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Chuize KongDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Yuyan ZhuDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Cancer immunotherapy is the use of the immune system to treat cancer. After years of research, there have been a significant number of publications in this field. We analyzed the literature and performed a hotspot analysis to identify important areas of future scientific research. MATERIAL AND METHODS Articles (2945) related to cancer immunotherapy published in the past 3 years were selected as the research sample. BICOMB software was then used to retrieve the high-frequency words and construct a text/co-word matrix. Next, gCLUTO software was used to analyze the matrix by double-clustering and visual analysis, in a strategy of hotspot identification. RESULTS We constructed a text and co-word matrix composed of 40 high-frequency words and 2945 articles and generated a hotspot "peak map" based on double-clustering analysis. The strategic coordinates were set by use of a co-word matrix and clustering analysis. The distribution of organs or disease and the subclass of cancer immunotherapy were analyzed. CONCLUSIONS In this study, we classified the hot-spots of "tumor immunotherapy" into 6 categories and 8 aspects. Calculation and analysis revealed that the field of tumor immunotherapy shows a slight trend of polarization, and the immune checkpoint inhibitor PD1 blocker shows the greatest potential for future development.

Indexed as

BibliometricsImmunotherapyCluster AnalysisHumansMedical Subject HeadingsNeoplasmsPublicationsSurveys and Questionnaires

Identifiers

PMID29790485
PMCPMC5994141
OpenAlexW2804198024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.